TSXV:CLAS.H - Post by User
Comment by
Bvukmanicon Feb 11, 2021 9:58pm
204 Views
Post# 32548868
RE:RE:RE:RE:Folks if you do not have plans to buy more shares yur
RE:RE:RE:RE:Folks if you do not have plans to buy more shares yur (another)agreement with Salzman group: Claritas will enter into a strategic collaboration with the Salzman Group, under which the Salzman Group will make available to Claritas the full capabilities of Salzman Group, including their deep expertise in working with nitric oxide and nitric oxide releasing compounds
(another)Private Placement with Echelon to fund a yet started Phase 1 Study: - Estimated Cost of Phase 1 Clinical Study: The estimated cost of the Phase 1 study is CAD $1,040,000. Claritas will work with Echelon Wealth Partners to complete a private placement financing to fund the R&D cost of the Phase 1 study, as well as funding for 12-months of G&A expense
A plan to ask for Gov't Funds once Phase 1 is complete:
Follow-On Clinical Studies: Following completion of the Phase 1 study, Claritas intends to apply for funding from the U.S. Department of Health and Human Services for the further development of R-107 in COVID-19 infection
What happened to applying for funding back in July? Why apply after they fund p1, which is also nearly twice as expensive as they said back in May. Salzman...all I need to say.